The relationship between the soluble Klotho protein and the residual renal function among peritoneal dialysis patients

Clinical and Experimental Nephrology

Volumn 16, Issue 3, 2012, Pages 442-447

  Akimoto, Tetsu ^a   Shiizaki, Kazuhiro ^b   Sugase, Taro ^b   Watanabe, Yuko ^a   Yoshizawa, Hiromichi ^a   Otani, Naoko ^a   Numata, Akihiko ^a   Takeshima, Eri ^a   Yamazaki, Tomoyuki ^a   Miki, Takuya ^a   Ito, Chiharu ^a   Pastor, Johanne V ^b   Iwazu, Yoshitaka ^a   Saito, Osamu ^a   Muto, Shigeaki ^a   Kuro O, Makoto ^b   Kusano, Eiji ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Chronic kidney disease; ELISA; Klotho; Peritoneal dialysis; Residual renal function

Indexed keywords

ALBUMIN; KLOTHO PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSATE; ENZYME IMMUNOASSAY; FEMALE; HEMODIALYSIS PATIENT; HUMAN; KLOTHO PROTEIN BLOOD LEVEL; KLOTHO PROTEIN URINE LEVEL; MALE; PERITONEAL DIALYSIS; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; TREATMENT DURATION; URINARY EXCRETION;

BIOLOGICAL MARKERS; GLUCURONIDASE; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; PERITONEAL DIALYSIS; SOLUBILITY;

EID: 84863720655     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-011-0582-2     Document Type: Article

References (25)

1. Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997;390:45-51.
2. Kuro-o M. Klotho. Pflugers Arch. 2010;459:333-43.
3. Chen CD, Podvin S, Gillespie E, Leeman SE, Abraham CR. Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17. Proc Natl Acad Sci USA. 2007;104:19796-801.
4. Imura A, Iwano A, Tohyama O, Tsuji Y, Nozaki K, Hashimoto N, et al. Secreted Klotho protein in sera and CSF: Implication for post-Translational cleavage in release of Klotho protein from cell membrane. FEBS Lett. 2004;565:143-7.
5. Hu MC, Shi M, Zhang J, Quiñones H, Kuro-o M, Moe OW. Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective. Kidney Int. 2010;78:1240-51.
6. Kusano E. Mechanism by which chronic kidney disease causes cardiovascular disease and the measures to manage this phenomenon. Clin Exp Nephrol. 2011;15:627-33.
7. Haruna Y, Kashihara N, Satoh M, Tomita N, Namikoshi T, Sasaki T, et al. Amelioration of progressive renal injury by genetic manipulation of Klotho gene. Proc Natl Acad Sci USA. 2007; 104:2331-6.
8. Koh N, Fujimori T, Nishiguchi S, Tamori A, Shiomi S, Nakatani T, et al. Severely reduced production of klotho in human chronic renal failure kidney. Biochem Biophys Res Commun. 2001;280: 1015-20.
9. Canada-USA (CANUSA) peritoneal dialysis study group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes. J Am Soc Nephrol. 1996;7: 198-207.
10. Watson PE, Watson ID, Batt RD. Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr. 1980;33:27-39.
11. Yamazaki Y, Imura A, Urakawa I, Shimada T, Murakami J, Aono Y, et al. Establishment of sandwich ELISA for soluble alpha-Klotho measurement: Age-dependent change of soluble alpha-Klotho levels in healthy subjects. Biochem Biophys Res Commun. 2010;398:513-8.
12. Akimoto T, Liapis H, Hammerman MR. Microvessel formation from mouse embryonic aortic explants is oxygen and VEGF dependent. Am J Physiol Regul Integr Comp Physiol. 2002;283: R487-95.
13. van Olden RW, Krediet RT, Struijk DG, Arisz L. Measurement of residual renal function in patients treated with continuous ambulatory peritoneal dialysis. J Am Soc Nephrol. 1996;7: 745-50.
14. Moist LM, Port FK, Orzol SM, Young EW, Ostbye T, Wolfe RA, et al. Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol. 2000;11:556-64.
15. Feinfeld DA, Danovitch GM. Factors affecting urine volume in chronic renal failure. Am J Kidney Dis. 1987;10:231-5.
16. Levey AS, Madaio MP, Perrone RD. Laboratory assessment of renal disease: Clearance, urinalysis, and renal biopsy. In: Brenner BM, Rector FC, editors. The kidney. 4th ed. Philadelphia: WB Saunders; 1991. p. 919-68.
17. Carvounis CP, Nisar S, Guro-Razuman S. Significance of the fractional excretion of urea in the differential diagnosis of acute renal failure. Kidney Int. 2002;62:2223-9.
18. Akimoto T, Ito C, Kato M, Ogura M, Muto S, Kusano E. Reduced hydration status characterized by disproportionate elevation of blood urea nitrogen to serum creatinine among the patients with cerebral infarction. Med Hypotheses. 2011;77:601-4.
19. Blake PG. Integrated end-stage renal disease care: The role of peritoneal dialysis. Nephrol Dial Transplant. 2001;16(Suppl 5):61-6.
20. Jansen MA, Hart AA, Korevaar JC, Dekker FW, Boeschoten EW. NECOSAD Study Group. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int. 2002;62:1046-53.
21. Lindholm B, Bergström J. Protein and amino acid metabolism in patients undergoing continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol. 1988;30(Suppl 1):S59-63.
22. Bergström J, Fürst P, Alvestrand A, Lindholm B. Protein and energy intake, nitrogen balance and nitrogen losses in patients treated with continuous ambulatory peritoneal dialysis. Kidney Int. 1993;44:1048-57.
23. Blumenkrantz MJ, Gahl GM, Kopple JD, Kamdar AV, Jones MR, Kessel M, et al. Protein losses during peritoneal dialysis. Kidney Int. 1981;19:593-602.
24. Kabanda A, Goffin E, Bernard A, Lauwerys R, van Ypersele de Strihou C. Factors influencing serum levels and peritoneal clearances of low molecular weight proteins in continuous ambulatory peritoneal dialysis. Kidney Int. 1995;48:1946-52.
25. Sugiura H, Tsuchiya K, Nitta K. Circulating levels of soluble a-Klotho in patients with chronic kidney disease. Clin Exp Nephrol. 2010;15:795-6.